Ortho RTi Signs Agreement with a Leading CMO for the Manufacture of cGMP Finished Dosage Form Ortho-R in Preparation for Planned First-in-Human Study.
In: Marketwired, 2018-09-06
Zeitungsartikel
Zugriff:
Titel: |
Ortho RTi Signs Agreement with a Leading CMO for the Manufacture of cGMP Finished Dosage Form Ortho-R in Preparation for Planned First-in-Human Study.
|
---|---|
Zeitschrift: | Marketwired, 2018-09-06 |
Veröffentlichung: | 2018 |
Medientyp: | Zeitungsartikel |
Sonstiges: |
|